Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Lu-Ming Liu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109109676. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper

Papers 11

  1. Integrated Analyses Identify Immune-Related Signature Associated with Qingyihuaji Formula for Treatment of Pancreatic Ductal Adenocarcinoma Using Network Pharm… Co-author DOI 10.1155/2020/7503605↗
  2. A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2018.12.010↗
  3. Magnesium transporter protein solute carrier family 41 member 1 suppresses human pancreatic ductal adenocarcinoma through magnesium-dependent Akt/mTOR inhibiti… Co-author DOI 10.18632/aging.101940↗
  4. Babaodan Capsule () combined with Qingyi Huaji Formula () in advanced pancreatic cancer-a feasibility study. Last author DOI 10.1007/s11655-017-2279-1↗
  5. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Last author DOI 10.18632/oncotarget.6450↗
  6. Establishment of a pancreatic cancer stem cell model using the SW1990 human pancreatic cancer cell line in nude mice. Last author DOI 10.7314/apjcp.2015.16.2.437↗
  7. MicroRNA expression in salivary supernatant of patients with pancreatic cancer and its relationship with ZHENG. Co-author DOI 10.1155/2014/756347↗
  8. Huachansu injection inhibits metastasis of pancreatic cancer in mice model of human tumor xenograft. Last author DOI 10.1186/1472-6882-14-483↗
  9. Electroacupuncture treatment for pancreatic cancer pain: a randomized controlled trial. Last author DOI 10.1016/j.pan.2013.10.007↗
  10. Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli. Last author DOI 10.2147/ott.s49148↗
  11. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF. Last author DOI 10.1177/1534735411400315↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhen Chen · 4 shared papers, 2012–2019 · strength 0.29
  2. Song Gao · 4 shared papers, 2014–2017 · strength 0.28
  3. Yong-Qiang Hua · 3 shared papers, 2013–2019 · strength 0.21
  4. Ai Qin Zhang · 1 shared paper, 2020 · strength 0.15
  5. Xiang Qian · 1 shared paper, 2020 · strength 0.15
  6. Peng Wang · 2 shared papers, 2014–2016 · strength 0.12
  7. Jian-Hua Yin · 2 shared papers, 2012–2014 · strength 0.10
  8. Zhi Qiang Meng · 1 shared paper, 2019 · strength 0.10
  9. Hui-Feng Gao · 1 shared paper, 2019 · strength 0.10
  10. Jing Xie · 1 shared paper, 2019 · strength 0.10
  11. Hao Chen · 1 shared paper, 2019 · strength 0.10
  12. Ke Zhang · 1 shared paper, 2019 · strength 0.10
  13. Chien‐shan Cheng · 1 shared paper, 2019 · strength 0.10
  14. Li-bin Song · 1 shared paper, 2017 · strength 0.09
  15. Qian Xiang · 1 shared paper, 2017 · strength 0.09
  16. Yan Pan · 1 shared paper, 2015 · strength 0.07
  17. Yongqiang Hua · 1 shared paper, 2016 · strength 0.06
  18. Zhiqiang Meng · 1 shared paper, 2016 · strength 0.06
  19. Zhen Chen · 1 shared paper, 2014 · strength 0.06
  20. Lianyu Chen · 1 shared paper, 2014 · strength 0.06
  21. Hao Chen · 1 shared paper, 2013 · strength 0.04
  22. Jin-bin Han · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.